CN
CN
CN

News 2024-09-09

Join Porton and Industry Elites at Pharma Crystallization Summit 2024!


As a proud gold sponsor of the Pharma Crystallization Summit 2024 (PCS 2024), the Crystallization Team at Porton, with locations in New Jersey (USA) and Shanghai (China), offers expert services in polymorph discovery and selection, crystallization process development, particle engineering, DS-DP co-processing, and pre-formulation evaluation.

The technical experts from Porton, Dr. Jian Wang and Dr. Yuriy Abramov, will serve as forum hosts and participate in the entire event. We invite industry elites from around the world to join us at the Crowne Plaza Hotel in Princeton, New Jersey, USA.


Conference Highlights

Convene Pioneers in Drug R&D and Top Crystallization Experts from Industry and Academia

Including representatives from Pfizer, AbbVie, Amgen, Eli Lilly & Co, Merck, GSK, as well as Carnegie Mellon University, Imperial College, and Rowan University.

Features a New Technical Solution Poster Session

Offering attendees more opportunities to engage face-to-face with top experts and diverse solution providers in the industry.

Wide Coverage of the Agenda

Covering core topics throughout the entire drug development lifecycle, from fundamental scientific research to industrial application, aiming to provide efficient technological solutions for challenges at different stages of new drug development.

Industry Pain Point Solutions

Helping crystallization and formulation solution providers accurately address industry pain points and efficiently offer customized solutions, jointly driving innovation and development in pharmaceutical crystallization technology.


Agenda


Honored Speaker


Register NOW to join industry elites at the premier crystallization event!

Please follow this registration link:

https://crystallizationsummit.com/2024-2/2024-registration/


  • Sponsors continually being added

Become part of Porton's community to access personalized insights and resources.
Subscribe for the Newsletter
By clicking “Subscribe,” you acknowledge that you have read and agree to our Legal Disclaimer, Terms of Use, and Privacy & Cookie Policy. Porton will use the contact information you provide to communicate with you about our products, services, and other relevant updates. You may unsubscribe at any time. For more information about how we protect your privacy and manage your communication preferences, please review our Privacy & Cookie Policy.

ⓒ 2025 PORTON Legal Notices | Porton Privacy

This website provides information on products tailored for a diverse audience and may include product details or information that are not readily accessible or valid in your country. Please note that we do not accept any responsibility for accessing such information in a manner that may violate any legal processes, regulations, registrations, or usage guidelines in your country of origin.

Become part of Porton's community to access personalized insights and resources.
Submit
By clicking “Subscribe,” you acknowledge that you have read and agree to our Legal Disclaimer, Terms of Use, and Privacy & Cookie Policy. Porton will use the contact information you provide to communicate with you about our products, services, and other relevant updates. You may unsubscribe at any time. For more information about how we protect your privacy and manage your communication preferences, please review our Privacy & Cookie Policy.

ⓒ 2025 PORTON Legal Notices | Porton Privacy

US: (609) 860-1300
CN: (86) 23-8608-3200